IR@PKUHSC  > 北京大学临床肿瘤学院
学科主题临床医学
Phase III study of afatinib vs placebo as adjuvant therapy after chemo-radiotherapy (CRT) in primary unresected patients with locoregionally advanced (LA) head and neck squamous cell carcinoma (HNSCC) in Asia: LUX-Head & Neck 4 (LUX-H&N4)
Hu, C. S.1; Chan, A.2; Gao, L.3; Ahn, M. -J.4; Cohen, E.5; Ang, M. -K.6; Cheng, Y.7; Hu, Q.8; Kim, S. -B.9; Li, P.10; Sun, Y.11; Fan, B.12; Cheng, G.13; Ehrnrooth, E.14; Wang, C. -H.15
刊名ANNALS OF ONCOLOGY
2015-12-01
suppl.9页:100-100
收录类别SCI ; ISTP
文章类型Meeting Abstract
WOS标题词Science & Technology
类目[WOS]Oncology
研究领域[WOS]Oncology
语种英语
WOS记录号WOS:000367158700338
引用统计
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/65199
专题北京大学临床肿瘤学院
作者单位1.Natl Canc Ctr, Dept Med Oncol, Singapore, Singapore
2.Tumor Hosp Jilin Prov, Div Thorac Oncol, Changchun, Peoples R China
3.Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea
4.Fudan Univ, Shanghai Canc Ctr, Shanghai 200433, Peoples R China
5.Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Hong Kong, Hong Kong, Peoples R China
6.Chinese Acad Med Sci, Canc Inst & Hosp, Beijing 100730, Peoples R China
7.Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
8.Univ Calif San Diego, Dept Med, Moores Canc Ctr, La Jolla, CA 92093 USA
9.Zhejiang Canc Hosp, Head & Neck Canc Ctr, Hangzhou, Zhejiang, Peoples R China
10.Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China
11.Peking Univ, Canc Hosp, Sch Oncol, Beijing 100871, Peoples R China
12.Boehringer Ingelheim China Investment Co Ltd, Med, Shanghai, Peoples R China
13.Boehringer Ingelheim China Investment Co Ltd, Biometr & Data Management, Shanghai, Peoples R China
14.Boehringer Ingelheim GmbH & Co KG, TA Oncol, Copenhagen, Denmark
15.Chang Gung Mem Hosp Keelung, Dept Canc Ctr, Taipei, Taiwan
推荐引用方式
GB/T 7714
Hu, C. S.,Chan, A.,Gao, L.,et al. Phase III study of afatinib vs placebo as adjuvant therapy after chemo-radiotherapy (CRT) in primary unresected patients with locoregionally advanced (LA) head and neck squamous cell carcinoma (HNSCC) in Asia: LUX-Head & Neck 4 (LUX-H&N4)[J]. ANNALS OF ONCOLOGY,2015,suppl.9:100-100.
APA Hu, C. S..,Chan, A..,Gao, L..,Ahn, M. -J..,Cohen, E..,...&Wang, C. -H..(2015).Phase III study of afatinib vs placebo as adjuvant therapy after chemo-radiotherapy (CRT) in primary unresected patients with locoregionally advanced (LA) head and neck squamous cell carcinoma (HNSCC) in Asia: LUX-Head & Neck 4 (LUX-H&N4).ANNALS OF ONCOLOGY,suppl.9,100-100.
MLA Hu, C. S.,et al."Phase III study of afatinib vs placebo as adjuvant therapy after chemo-radiotherapy (CRT) in primary unresected patients with locoregionally advanced (LA) head and neck squamous cell carcinoma (HNSCC) in Asia: LUX-Head & Neck 4 (LUX-H&N4)".ANNALS OF ONCOLOGY suppl.9(2015):100-100.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Hu, C. S.]的文章
[Chan, A.]的文章
[Gao, L.]的文章
百度学术
百度学术中相似的文章
[Hu, C. S.]的文章
[Chan, A.]的文章
[Gao, L.]的文章
必应学术
必应学术中相似的文章
[Hu, C. S.]的文章
[Chan, A.]的文章
[Gao, L.]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。